REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Bioceuticals S.A. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Bioceuticals S.A. Profile Updated: June 27, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Bioceuticals S.A. is based in Ecuador. The head office is in Quito. The enterprise currently operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The company was established on March 24, 2009. The total number of employees is currently 7 (2022). In 2022, the company reported a net sales revenue drop of 6.43%. There was a total growth of 36.21% in Bioceuticals S.A.’s total assets over the same period. The enterprise’s net profit margin increased by 39.41% in 2022.

Headquarters
Av. Eugenio Espejo N2410 , Floor 302
Quito; Pichincha;

Contact Details: Purchase the Bioceuticals S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Bioceuticals S.A. report to view the information.
Outstanding Shares:
Purchase the Bioceuticals S.A. report to view the information.
Registered Capital:
Purchase the Bioceuticals S.A. report to view the information.
Incorporation Date:
March 24, 2009
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
51%
Purchase this report to view the information.
24.5%
Purchase this report to view the information.
12.25%
Purchase this report to view the information.
12.25%
Company Performance
Financial values in the chart are available after Bioceuticals S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-6.43%▼
Total operating revenue
-8.9%▼
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
98.49%▲
Total assets
36.21%▲
Total equity
N/A
Operating Profit Margin (ROS)
N/A
Net Profit Margin
39.41%▲
Return on Equity (ROE)
N/A
Debt to Equity Ratio
N/A
Quick Ratio
10.58%▲
Cash Ratio
5.91%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo